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Abstract
Background: Attention deficits belong to the main cognitive symptoms of schizophrenia and come along with
altered neural activity in previously described cerebral networks. Given the high heritability of schizophrenia the
question arises if impaired function of these networks is modulated by susceptibility genes and detectable in
healthy risk allele carriers.
Methods: The present event-related fMRI study investigated the effect of the single nucleotide polymorphism
(SNP) rs1018381 of the DTNBP1 (dystrobrevin-binding protein 1) gene on brain activity in 80 subjects while
performing the attention network test (ANT). In this reaction time task three domains of attention are probed
simultaneously: alerting, orienting and executive control of attention.
Results: Risk allele carriers showed impaired performance in the executive control condition associated with
reduced neural activity in the left superior frontal gyrus [Brodmann area (BA) 9]. Risk allele carriers did not show
alterations in the alerting and orienting networks.
Conclusions: BA 9 is a key region of schizophrenia pathology and belongs to a network that has been shown
previously to be involved in impaired executive control mechanisms in schizophrenia. Our results identified the
impact of DTNBP1 on the development of a specific attention deficit via modulation of a left prefrontal network.
Background
Attention deficits belong to the most prominent impair-
ments among a wide range of cognitive deficits in schi-
zophrenia patients [1]. In recent theories the concept of
attention has been divided into three subdomains
including “alerting”, “orienting” and “executive control”
[2,3]. Alerting comprises the cognitive control of wake-
fulness and arousal (intrinsic alertness) and the ability to
increase response readiness for a short period of time
subsequent to external cues (phasic alertness) [4].
Orienting refers to the overt or covert directing of spa-
tial attention to unattended stimuli. Executive control of
attention requires the ability to respond to one aspect of
a stimulus while ignoring another (more dominant)
aspect. In schizophrenia, deficits have been demon-
strated in each of these three attentional subdomains
[5-8]. To a lesser extent, impaired attention can also be
found in non-psychotic relatives of schizophrenia
patients. Accordingly, attention deficits might index
genetic liability [9-13].
Investigating the neural correlates of attention deficits
in schizophrenia patients and groups at genetic risk
compared to healthy subjects might elucidate the
mechanisms how genes can lead to the manifestation of
a cognitive deficit. In healthy subjects, functional ima-
ging studies have shown distinct neural networks under-
lying each of the three above mentioned attentional
domains. Alerting has been shown to rely on thalamic,
prefrontal and parietal areas [4,14-16]. Orienting has
been associated with activation of the superior parietal
lobe, temporal parietal junction, and frontal eye fields
[14,17-19]. Executive control of attention has been con-
sistently related to activation of the anterior cingulate
and lateral prefrontal cortex [14,20-23]. While networks
of alerting and orienting are lateralized to the right
hemisphere [3,4,18], executive control shows a left
lateral prefrontal bias [23,24].
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Functional imaging studies have revealed dysfunctions
of these networks in schizophrenia patients associated
with the performance of attentional tasks requiring
alerting, orienting or executive control [25-27]. Likewise,
in relatives of schizophrenia patients, alterations have
been found in networks of various cognitive domains
[28] and in particular of the attention systems [29-31].
Neural abnormalities in relatives were similar to those
in schizophrenia patients, and it was suggested that
reduced BOLD activity in attention networks may be an
intermediate marker for schizophrenia [31].
The studies in relatives have shown that genetic liabi-
lity in general affects neural correlates of attention.
However, schizophrenia has a polygenetic pattern of
heredity and the impact of single genes on neural net-
works of cognition is largely unknown. Fan et al. [32]
found that polymorphisms in dopamine receptor
(DRD4) and monoamine oxidase A (MAOA) genes led
to impaired executive control of attention in healthy
subjects and that this was associated with reduced
neural activity of the anterior cingulate cortex. The
effect of (other) single gene variants on neural networks
in healthy subjects has recently also been shown for
other cognitive domains [33-41].
Several susceptibility genes for schizophrenia have
been detected in recent years, including DTNBP1, neur-
egulin 1 (NRG1), catechol-O-methyltransferase (COMT),
disrupted-in-schizophrenia 1 (DISC1), regulator of G-
protein signalling 4 (RGS4), G72, proline dehydrogenase
(PRODH), and D-amino acid oxidase (DAAO) [42-44].
Among these, DTNBP1 stands out as one of the best
replicated susceptibility genes [45,46]. It has been shown
to affect personality traits [47,48], intelligence [49-53],
attention capacity [47], verbal fluency [37,52] and several
memory domains [52-55] in both healthy subjects and
patients with schizophrenia. In particular, negative
symptoms in schizophrenia have been shown to be asso-
ciated with several SNP of the DTNBP1 gene [56,57].
The effect of DTNBP1 on cognitive functions has been
supposed to be mediated by the glutamate neurotrans-
mitter system, acting via the prefrontal cortex [58]. In a
gene expression study, Weickert et al. [59] showed that
DTNBP1 mRNA levels varied depending on the
DTNBP1 genotype and that schizophrenia patients
showed significantly reduced DTNBP1 mRNA levels in
the dorsolateral prefrontal cortex. Several SNPs of
DTNBP1 have been detected and discussed as risk fac-
tors for schizophrenia [60]. In particular, the minor T
allele of the SNP rs1018381 (P1578) which has a fre-
quency of about 9% in the Caucasian population [61]
can be regarded as an important risk factor. It has been
shown to be strongly associated with schizophrenia in
two of three independent samples of different ethnic
origin (white and Hispanic, but not African American;
[62]. In a study by Burdick et al. [49], this SNP was also
the only one that showed a significant effect on general
cognitive ability in patients and controls. Finally, a
recent study on healthy individuals by Luciano et al.
[52] provided further evidence for an association
between the rs1018381 minor T allele and cognitive def-
icits in an Australian and Scottish cohort and a trend
for an association was found for the English cohort.
The aim of the present study was to investigate the
effects of SNP rs1018381 of the DTNBP1 gene on neural
attention networks of alerting, orienting and executive
control in healthy subjects. As an activation paradigm
we used a modified version of the attention network test
(ANT) developed by Fan et al. [63]. This test is capable
of probing the three attention networks in one single
reaction time task. Gene effects were expected to occur
in brain areas known to be involved in alerting, orient-
ing or executive control and to be impaired in schizo-
phrenia patients. We hypothesized that risk allele
carriers show reduced neural activity in
(1) prefrontal and parietal areas (with a right hemi-
sphere bias) associated with alerting.
(2) superior parietal areas and the temporal parietal
junction (with a right hemisphere bias) associated with
orienting.
(3) anterior cingulate cortex and lateral prefrontal
areas (with a left hemisphere bias) associated with
executive control of attention.
Materials and methods
Subjects
Eighty participants were recruited from the RWTH
Aachen university. Inclusion criteria were age (18-55
years), right-handedness (assessed by the Edinburgh
Laterality Scale [64]) and no psychiatric disorder accord-
ing to ICD-10. The study protocol was approved by the
local ethics committee and each participant gave written
informed consent.
Genetic analysis
DNA was obtained from peripheral lymphocytes by a
simple salting out procedure. The SNP rs1018381 [60]
was genotyped using Applied Biosystems 7900HT Fast
Real-Time PCR System and TaqMan-probes designed
by Applied Biosystems (Foster City, California). For
detection of the SNP rs1018381 the following Primers
and VIC/FAM-probe sequences were used: Forward-5′-
GAGTTACAAGTAAATGAAACGTCATGCA-3′;
Reverse-5′-GCTGAGATCTGCCGGTGATTC-3′; 5′-
VIC-ACAGCGTGCGGAAC-3′; 5′-FAM- AACAG-
CATGCGGAAC. Note, that compared to previous stu-
dies by other groups, the common C allele is equivalent
to our G allele and analogous the risk T allele [49,60,62]
is equivalent to our A allele. The allele distribution in
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our total sample did not differ from the expected fre-
quencies of SNP rs1018381 genotypes in a Caucasian
sample [61]: 0,008 (A/A), 0,162 (A/G) and 0,830 (G/G).
This was verified by Hardy-Weinberg equilibrium
(HWE) using Haldane’s exact test [65].
fMRI task and stimuli
The fMRI task was designed with “Presentation” soft-
ware (Neurobehavioral Systems Inc., San Francisco, CA)
and was a modified version of the original attention net-
work test (ANT) by Fan et al. [63]. Three cue conditions
(no cue, center cue, spatial cue), two target conditions
(congruent, incongruent) and two visual field conditions
(left, right) were used (see Figure 1). As a cue an aster-
isk was used, appearing either at the center of the
screen where it replaced a fixation cross (center cue) or
lateralized next to the fixation cross, where it indicated
the location of the following target stimulus (spatial
cue). Targets consisted of a block of 5 parallel horizon-
tal lines, with arrowheads pointing leftward or right-
ward. Target blocks were displaced approximately 4
degrees either left or right from the center (visual field
condition). The middle of the 5 arrows was the target
stimulus which had to be attended to. It was located at
the horizontal midline. The other 4 arrows (two above
and two below the target stimulus) served as distractors.
In each trial, all distractor arrows pointed either to the
same direction (congruent condition) or to the opposite
direction (incrongruent condition) as the target arrow.
Stimulus material was presented in black against a white
background.
Each trial started with the presentation of a cue (or the
fixation cross in the “no cue” condition) that was dis-
played for 150 ms. Following an interstimulus interval
(ISI) of 400 ms (meanwhile the fixation cross was pre-
sented), the target (comprising target arrow and distrac-
tor arrows) appeared. Participants were required to
indicate the direction of the target arrow by pressing a
button with the left or right index finger corresponding
to the left or right direction of the target arrow, respec-
tively. Targets were presented for 1550 ms and followed
by a presentation of the fixation cross until the end of the
trial (i.e. presentation of the next cue). The duration of
the fixation cross was 400 ms plus a pseudo-randomized
multiple (0-9 times) of 500 ms, resulting in a total ISI of
400-4900 ms. Twenty trials were presented for each of
the 12 possible permutations of conditions in a pseudo-
randomized order, resulting in a total of 240 trials.
Figure 1 Stimulus material and example for the course of one trial (right spatial cue/incongruent target)
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Data acquisition
FMRI was performed on a 3-T Trio MR scanner (Sie-
mens, Erlangen, Germany) in the Institute of Neu-
roscience and Medicine - 4, Research Centre Jülich,
using a T2*-weighted echo planar imaging (EPI)
sequence (time repetition = 2200 ms, time echo = 30
ms, flip angle = 90°). Slices covered the whole brain and
were positioned transaxially parallel to the anterior-pos-
terior commissural line (AC-PC). A total of 391 func-
tional images were acquired, each consisting of 36 slices
(3 mm thickness, 20 × 20 cm field of view, 64 × 64
image matrix). The initial three images were excluded
from further analysis in order to remove the influence
of T1 stabilization effects.
fMRI data analysis
Analysis of fMRI data was done by SPM5 [66]. Func-
tional images were realigned to the first image, normal-
ized to the mean image (to a voxel size of 2 × 2 × 2
mm), smoothed (6 mm isotropic Gaussian filter) and
high-pass filtered (cut off period 128 s). Temporal auto-
correlations were removed using an autoregressive
model of order 1 (AR(1)). Trials with incorrect or miss-
ing responses were removed. Twelve onset regressors
(related to the onset of the targets) were defined result-
ing from the permutation of all conditions comprising 3
cues (no/center/spatial), 2 targets (congruent/incongru-
ent) and 2 target positions (left/right). The hemody-
namic response to each different event type was
modeled using a canonical synthetic hemodynamic
response function. The 6 head movement parameters
were included as confounds. In order to identify the
effects of a) alerting, b) orienting and c) executive con-
trol, first level linear contrasts were calculated, compar-
ing a) events of center cue versus no cue b) events of
spatial cue versus center cue and c) events of incongru-
ent targets versus congruent targets. At the second level,
the individual b-contrasts of the first level analyses were
used to calculate t-tests to investigate for genotype
effects (G/A vs. G/G) and for task effects in the whole
sample regardless of risk/non-risk status. Effects were
expected to occur in brain areas known to be involved
in alerting, orienting or executive control and to be
impaired in schizophrenia patients [25-27]. According to
the present literature, specific regions of interests (ROIs)
for each attentional subdomain were defined as follows:
alerting = right hemisphere prefrontal and parietal areas
[3,4,14-16]; orienting = right hemisphere parietal areas
[3,14,17-19]; executive control of attention = left hemi-
sphere prefrontal areas [14,20-24]. The prefrontal areas
included the superior, middle and inferior frontal gyrus
as well as the ACC. Analyses were performed with a
predefined threshold of p < .001 (uncorrected). Accord-
ing to Thirion and coworkers [67] this is the optimal
threshold in fMRI studies with regard to sensitivity and
reliability. We are aware of the problem that the absence
of correction for multiple testing enlarges the risk to
commit the alpha error, i.e. to assume a between group
difference that in reality does not exist. However, we
consider that there are two reasons that legitimate our
procedure: 1. We have a hypothesis about the areas that
we expect to be activated and only look for results in
predefined areas. 2. The disadvantage of a (conservative)
correction for multiple comparisons is that the more
you guard against the alpha error the higher the risk is
to commit the beta error, i.e. not to detect an existing
difference. The exploratory character of our results in
the still relatively new research field of genetic imaging
favours the use of this rather liberal significance
threshold.
Behavioral data analysis
Attentional effects were calculated as differential (d)
scores from reaction times and error rates as follows: (1)
alerting = (no cue) - (center cue); (2) orienting = (center
cue) - (spatial cue); (3) executive control = (incongruent
targets) - (congruent targets). Group differences (risk vs.
non risk) for each attentional effect were proved by
ANOVA.
Results
Subjects
Genetic analysis of SNP rs1018381 revealed 29 subjects
with the risk allele variant A/G and 51 subjects with the
non risk variant G/G. Risk group and non risk group
did not differ concerning sex ratio, age, education and
estimated IQ (see Table 1).
Behavioral data
The total group showed significant effects in alerting (d
= 24 ± 21 ms; T = 10.1; p < .001), orienting (d = 40 ±
28 ms; T = 12.9; p < .001) and executive control (d = 54
± 26 ms; T = 18.7; p < .001). The executive control
effect was significantly greater (T = 1.80; p = .038) in
the risk group (d = 61 ± 29 ms) than in the non risk
group (d = 50 ± 23 ms; see Figure 2). No group differ-
ences were found for the alerting and orienting effect.
fMRI data
Group differences were investigated for alerting, orient-
ing and executive control in the predefined ROIs. Dur-
ing executive control, the group of risk allele carriers
showed reduced neural activity in the left BA 9 of the
superior frontal gyrus (Talairach coordinates [TC]: -18
44 18; cluster size [k]: 13 voxel; T = 3.81; p < .001
uncorrected, see Figure 3). A within group analysis of
the total group (without respect to the genotype)
revealed neural activity in a left prefrontal area. This
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Table 1 Sociodemographic variables of the sample; means (standard deviations in parentheses)
Sample (n = 80) Risk group (n = 29) Non risk group (n = 51) Statistics p
Sex ratio (men/women) 22/7 32/19 c2 = 1.45 n.s.
Age 22.6 (2.3) 23.6 (3.2) T = 1.57 n.s.
Education (years) 15.3 (2.2) 15.9 (2.8) T = 0.94 n.s.
Estimated IQ 113.8 (11.3) 111.0 (13.2) T = 0.93 n.s.
IQ was estimated using the MWT-B (Lehrl, 2005);
n.s. = non significant (p > .05);
Figure 2 Effect of genotype on attentional effects
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was located in the white matter close to the middle/
inferior frontal gyrus (TC: -32 39 2; k: 10 voxel; T =
3.41; p < .001 uncorrected). No group differences were
found for alerting and orienting. A correlation between
the degree of activation in the above mentioned cluster
and the behavioral performance of executive control
revealed a Pearson coefficient = -.099 which was not sig-
nificant (p = .19).
Discussion
The present fMRI study investigated the effect of the
SNP rs1018381 of the DTNBP1 gene on attention net-
works. We used the well-established attention network
test [14] to examine the three attentional domains
“alerting”, “orienting” and “executive control”. No geno-
type effect was found for the alerting and orienting con-
dition. However, in the executive control condition, risk
allele carriers showed reduced neural activity in the left
superior frontal gyrus (BA 9) when compared to the
non risk control group. This was associated with a beha-
vioral deficit in executive control that was reflected by a
greater reaction time difference between the “congruent”
and the “incongruent” condition where misleading infor-
mation of distractors caused response conflict and had
to be suppressed.
These results are well in line with previous studies
showing that left lateral prefrontal cortex and ACC are
the key regions of the executive control network in
Figure 3 Decreased neural activity during executive control of attention risk group (inc > con) <non risk group (inc > con); bar graph
shows mean betas of the GLM (arbitrary units)
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healthy subjects [14,20-24]. Furthermore these results
are in accordance with schizophrenia pathology of cog-
nition and neural functioning. In schizophrenia, deficits
in executive control as well as dysfunction of the left
prefrontal cortex and ACC are frequently reported find-
ings [7,68-71]. A direct association between executive
dysfunction and prefrontal cortex dysactivation in schi-
zophrenia has been demonstrated in functional imaging
studies [25,27]. Recent studies have shown that relatives
of schizophrenia patients tend to have the same dys-
functions in an attenuated degree on the behavioral and
neural level [28-31]. However, there is very limited evi-
dence about the effects of single genetic variants on
attention networks. In a behavioral study, Fossella et al.
[72] found associations between polymorphisms of four
candidate genes (DRD4, DAT, COMT, MAOA) and
reduced efficiency specifically for executive attention. In
a subsequent fMRI study, the effects of DRD4 and
MAOA genes were shown to be associated with less
activity in the ACC [32]. These dopaminergic genes had
been chosen for that study because they were likely to
affect the investigated networks since the prefrontal key
areas - particularly for the executive control network -
are known to be dopaminergic brain areas. However,
schizophrenia is a polygenetic disorder and genes coding
for other transmitter systems such as glutamate are also
likely to modulate attention networks via the ACC or
lateral prefrontal cortex. It has been found that dopa-
mine modulates prefrontal activity by affecting the excit-
ability of glutamatergic neurons [69] and that this
interaction is disturbed in schizophrenia patients [73].
Several studies have investigated the effect of DTNBP1
in the development of schizophrenia. They showed that
DTNBP1 is involved in the pre-synaptic protein expres-
sion and release of glutamate [74] and that schizophre-
nia patients have reduced DTNBP1 mRNA levels
especially in the prefrontal cortex [59]. It has been sup-
posed that particular DTNBP1 alleles increase the risk
for schizophrenia and affect cognitive functions
mediated by the glutamate neurotransmitter system
directly affecting the development, maturation, and
adult function of the prefrontal cortex [54,58,59].
Consistent with the interaction between dopaminergic
and glutamatergic neurons in the prefrontal lobe we
now found that the glutamatergic DTNBP1 gene led to
the same effects of disturbed function of the executive
control network in healthy risk gene carriers as Fan et
al [32] showed for the dopaminergic genes DRD4 and
MAOA. Our effects were specific for the left hemisphere
network of executive control of attention and no altera-
tions were found in the right hemisphere networks of
alerting and orienting. This result might be explained by
the different relevance of transmitter systems for distinct
brain regions and cognitive functions. Alerting and
orienting have been shown to rely on norepinephrine
and cholinergic networks, respectively [75,76] and there-
fore these attentional domains were less likely to be
affected by glutamatergic gene effects than executive
control of attention. Furthermore, disturbances of alert-
ing or orienting have been found to be less pronounced
in schizophrenia than executive control [7,77] and for
this reason it was also less likely to find dysfunctions of
those networks in healthy risk allele carriers.
Two fMRI studies by Markov et al. [37,40] have inves-
tigated the effects of DTNBP1 (SNP rs 1018381) on
working memory and verbal fluency in healthy subjects.
They found neural networks of risk allele associated
activation which did not match the cluster of our study.
This is not surprising since the underlying networks of
these cognitive domains differ from those of executive
control of attention.
Limitations
A limitation of our study is that we only studied the
most promising risk allele variant (A/G of the SNP
rs1018381) and it would be interesting to investigate the
effects of other SNPs as well. Furthermore, a direct
comparison of non psychotic risk gene carriers with a
group of schizophrenia patients would be desirable and
might lead to a better understanding of the aetiology of
attention deficits in schizophrenia.
Conclusions
Summarizing, our results elucidate the role of the
DTNBP1 gene in the development of a specific dysfunc-
tion of the neural network underlying executive control
of attention. Healthy risk allele carriers showed a beha-
vioral deficit in this cognitive domain that was asso-
ciated with reduced neural activity in the left superior
frontal gyrus (BA 9). This area is known as a key region
of schizophrenia pathology and belongs to a network
that has been shown previously to be involved in
impaired executive control mechanisms in schizophre-
nia. Thus, our results suggest that executive control def-
icits in schizophrenia might be codetermined by
DTNBP1 allele status and be based on a modification of
a left prefrontal network that is already emerging in
healthy risk allele carriers.
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